Heteroaryl and aliphatic analogs of diarylurea-based cannabinoid 1 receptor (CB1 R) allosteric modulators of formula (I) are described. Exemplary analogs can provide improved potencies and pharmacokinetic properties. Methods of using the analogs to treat diseases mediated by CB1 R, such as substance abuse and obesity are described.
基于二芳基
脲的
大麻素受体1(CB1 R)变构调节剂的杂环芳基和脂肪族类似物(I)的
化学式已被描述。示例类似物可以提供改进的效力和药代动力学特性。描述了使用这些类似物治疗由CB1 R介导的疾病的方法,如物质滥用和肥胖症。